Holocene Advisors’s Health Catalyst HCAT Stock Holding History

Holocene Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22,066	Closed	-$320K	–	866
2022 Q2	$320K	Sell	22,066 -43,860	-67%	-$748K	﹤0.01%	745
2022 Q1	$1.72M	Buy	+65,926	New	+$1.87M	0.01%	565
2021 Q3	–	Sell	-3,703	Closed	-$206K	–	878
2021 Q2	$206K	Buy	+3,703	New	+$197K	﹤0.01%	795
2021 Q1	–	Sell	-34,717	Closed	-$1.51M	–	852
2020 Q4	$1.51M	Buy	34,717 +24,937	+255%	+$920K	0.01%	469
2020 Q3	$358K	Buy	+9,780	New	+$332K	﹤0.01%	611

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Holocene Advisors's HCAT Position: Q3 2022 in Review

Holocene Advisors sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 22,066 shares — an estimated $320K sold.

Holocene Advisors first reported a position in HCAT in Q3 2020 and held it in 5 quarters. The position peaked at $1.72M in Q1 2022. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

Holocene Advisors reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
Holocene Advisors sold 22,066 Health Catalyst shares in Q3 2022, an estimated $320K.
Holocene Advisors first reported a position in Health Catalyst in Q3 2020 and held it in 5 quarters.
Holocene Advisors's Health Catalyst position peaked at $1.72M in Q1 2022.
171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Holocene Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.